These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 8180359
1. Current approaches to diagnosis and treatment of ovarian germ cell malignancies. Fishman DA, Schwartz PE. Curr Opin Obstet Gynecol; 1994 Feb; 6(1):98-104. PubMed ID: 8180359 [Abstract] [Full Text] [Related]
2. Combination chemotherapy in the management of ovarian germ cell malignancies. Schwartz PE. Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473 [Abstract] [Full Text] [Related]
3. Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gershenson DM. Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S62-72. PubMed ID: 7530680 [Abstract] [Full Text] [Related]
5. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study. Dimopoulos MA, Papadopoulou M, Andreopoulou E, Papadimitriou C, Pavlidis N, Aravantinos G, Aspropotamitis A, Anagnostopoulos A, Fountzilas G, Michalas S, Pectacides D. Gynecol Oncol; 1998 Jul; 70(1):70-4. PubMed ID: 9698477 [Abstract] [Full Text] [Related]
6. Current management of malignant germ cell tumor of the ovary. Aziz MF. Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594 [Abstract] [Full Text] [Related]
7. [Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor]. Hong W, Zhang R, Liu L. Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):35-7. PubMed ID: 10682456 [Abstract] [Full Text] [Related]
8. [Medical treatment of ovarian malignant germ cell tumors in the adult]. Culine S, Lhommé C, Droz JP. Bull Cancer; 1997 Sep; 84(9):919-21. PubMed ID: 9435816 [Abstract] [Full Text] [Related]
9. Malignant germ cell tumors: clinical characteristics, treatment, and outcome. A report from the study group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan. Suita S, Shono K, Tajiri T, Takamatsu T, Mizote H, Nagasaki A, Inomata Y, Hara T, Okamura J, Miyazaki S, Kawakami K, Eguchi H, Tsuneyoshi M, Committee for Pediatric Solid Malignant Tumors in the Kyushu Area. J Pediatr Surg; 2002 Dec; 37(12):1703-6. PubMed ID: 12483635 [Abstract] [Full Text] [Related]
11. [Comprehensive staging surgery in treatment of malignant ovarian germ cell tumor]. Jin Y, Pan LY, Huang HF, Shen K, Wu M, Yang JX, Lang JH. Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):826-30. PubMed ID: 16412329 [Abstract] [Full Text] [Related]
13. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial. Hinton S, Catalano PJ, Einhorn LH, Nichols CR, David Crawford E, Vogelzang N, Trump D, Loehrer PJ. Cancer; 2003 Apr 15; 97(8):1869-75. PubMed ID: 12673712 [Abstract] [Full Text] [Related]
14. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients. Li J, Yang W, Wu X. Gynecol Oncol; 2007 Jun 15; 105(3):769-75. PubMed ID: 17459461 [Abstract] [Full Text] [Related]
15. [Lymphadenectomy in the treatment of malignant ovarian germ cell tumor]. Jin Y, Pan LY, Huang HF, Shen K, Wu M, Yang JX, Lang JH. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec 15; 27(6):743-8. PubMed ID: 16447650 [Abstract] [Full Text] [Related]
16. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group. J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987 [Abstract] [Full Text] [Related]
17. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Bokemeyer C, Harstrick A, Beyer J, Metzner B, Rüther U, Hartmann JT, Holstein K, Derigs HG, de Wit R, Casper J, Schöffski P, Kührer I, Illiger HJ, Kempf B, Reichle A, Föller A, Hossfeld DK, Fischer JT, Berdel WE, Gerhartz HH, Kirchner H, Pflüger KH, Ostermann H, Kanz L, Schmoll HJ. Semin Oncol; 1998 Apr 15; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059 [Abstract] [Full Text] [Related]
18. Germ cell tumors of the ovary. Pectasides D, Pectasides E, Kassanos D. Cancer Treat Rev; 2008 Aug 15; 34(5):427-41. PubMed ID: 18378402 [Abstract] [Full Text] [Related]
19. [Characteristics of rare ovarian tumors--possibilities of organ preservation]. Grischke EM, Wallwiener D, Bastert G. Zentralbl Gynakol; 1996 Aug 15; 118(6):322-5. PubMed ID: 8768007 [Abstract] [Full Text] [Related]
20. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891. Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescorla F, Davis MM, London WB, Lauer SJ, Giller RH, Cushing B, Pediatric Oncology Group 9048, Children's Cancer Group 8891. J Clin Oncol; 2004 Sep 01; 22(17):3563-9. PubMed ID: 15337806 [Abstract] [Full Text] [Related] Page: [Next] [New Search]